Department of Ophthalmology, Xiang'an Hospital of Xiamen University, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute of Xiamen University, School of Medicine, Xiamen University, Xiamen City, FJ 361102, China.
Department of Anesthesiology, First Affiliated Hospital of Xiamen University, Xiamen City, FJ 361003, China.
J Biol Chem. 2020 May 15;295(20):6958-6971. doi: 10.1074/jbc.RA120.013189. Epub 2020 Apr 7.
Disrupted clearance of all-retinal (atRAL), a component of the visual (retinoid) cycle in the retina, may cause photoreceptor atrophy in autosomal recessive Stargardt disease (STGD1) and dry age-related macular degeneration (AMD). However, the mechanisms underlying atRAL-induced photoreceptor loss remain elusive. Here, we report that atRAL activates c-Jun N-terminal kinase (JNK) signaling at least partially through reactive oxygen species production, which promoted mitochondria-mediated caspase- and DNA damage-dependent apoptosis in photoreceptor cells. Damage to mitochondria in atRAL-exposed photoreceptor cells resulted from JNK activation, leading to decreased expression of Bcl2 apoptosis regulator (Bcl2), increased Bcl2 antagonist/killer (Bak) levels, and cytochrome (Cyt ) release into the cytosol. Cytosolic Cyt specifically provoked caspase-9 and caspase-3 activation and thereby initiated apoptosis. Phosphorylation of JNK in atRAL-loaded photoreceptor cells induced the appearance of γH2AX, a sensitive marker for DNA damage, and was also associated with apoptosis onset. Suppression of JNK signaling protected photoreceptor cells against atRAL-induced apoptosis. Moreover, photoreceptor cells lacking and genes were more resistant to atRAL-associated cytotoxicity. The mouse model displays defects in atRAL clearance that are characteristic of STGD1 and dry AMD. We found that JNK signaling was activated in the neural retina of light-exposed mice. Of note, intraperitoneal administration of JNK-IN-8, which inhibits JNK signaling, effectively ameliorated photoreceptor degeneration and apoptosis in light-exposed mice. We propose that pharmacological inhibition of JNK signaling may represent a therapeutic strategy for preventing photoreceptor loss in retinopathies arising from atRAL overload.
全视网膜(atRAL)清除受阻,这是视网膜视觉(类视黄醇)循环的一个组成部分,可能导致常染色体隐性遗传的斯塔加特病(STGD1)和干性年龄相关性黄斑变性(AMD)中的光感受器萎缩。然而,atRAL 诱导光感受器丧失的机制仍不清楚。在这里,我们报告 atRAL 通过活性氧(ROS)的产生至少部分激活 c-Jun N 端激酶(JNK)信号通路,从而促进光感受器细胞中线粒体介导的半胱天冬酶依赖性和 DNA 损伤依赖性细胞凋亡。在 atRAL 暴露的光感受器细胞中,ROS 的产生导致 JNK 激活,进而导致 Bcl2 凋亡调节因子(Bcl2)表达减少,Bcl2 拮抗剂/杀伤因子(Bak)水平增加,细胞色素 C(Cyt c)释放到细胞质中。细胞质 Cyt c 特异性引发半胱天冬酶-9 和半胱天冬酶-3 的激活,从而引发细胞凋亡。atRAL 负载的光感受器细胞中 JNK 的磷酸化诱导了 DNA 损伤的敏感标志物 γH2AX 的出现,并且与细胞凋亡的发生也有关。抑制 JNK 信号通路可保护光感受器细胞免受 atRAL 诱导的凋亡。此外,缺乏 和 基因的光感受器细胞对 atRAL 相关的细胞毒性更具抗性。 小鼠模型显示出与 STGD1 和干性 AMD 特征一致的 atRAL 清除缺陷。我们发现,在暴露于光线下的 小鼠的神经视网膜中激活了 JNK 信号通路。值得注意的是,腹腔内给予 JNK-IN-8(一种抑制 JNK 信号通路的药物)可有效改善暴露于光线下的 小鼠的光感受器变性和细胞凋亡。我们提出,抑制 JNK 信号通路可能是预防由 atRAL 过载引起的视网膜病变中光感受器丧失的一种治疗策略。